Zytoprotec
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas.
Launch date
Market cap
-
Enterprise valuation
CAD12—18m (Dealroom.co estimates Jan 2013.)
Delta Junction Alaska (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
€2.0m | Series A | ||
| Total Funding | CAD3.0m | ||
Related Content
Recent News about Zytoprotec
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.